These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 24696726)

  • 1. Expression of glutaminase is upregulated in colorectal cancer and of clinical significance.
    Huang F; Zhang Q; Ma H; Lv Q; Zhang T
    Int J Clin Exp Pathol; 2014; 7(3):1093-100. PubMed ID: 24696726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glutaminase 1 expression in colorectal cancer cells is induced by hypoxia and required for tumor growth, invasion, and metastatic colonization.
    Xiang L; Mou J; Shao B; Wei Y; Liang H; Takano N; Semenza GL; Xie G
    Cell Death Dis; 2019 Jan; 10(2):40. PubMed ID: 30674873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Upregulated SLC1A5 promotes cell growth and survival in colorectal cancer.
    Huang F; Zhao Y; Zhao J; Wu S; Jiang Y; Ma H; Zhang T
    Int J Clin Exp Pathol; 2014; 7(9):6006-14. PubMed ID: 25337245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glutaminase sustains cell survival via the regulation of glycolysis and glutaminolysis in colorectal cancer.
    Song Z; Wei B; Lu C; Li P; Chen L
    Oncol Lett; 2017 Sep; 14(3):3117-3123. PubMed ID: 28928849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of anti-tumor effect and mechanism of GLS1 inhibitor CB-839 in colorectal cancer using a stroma-abundant tumor model.
    Miyamoto R; Takigawa H; Yuge R; Shimizu D; Ariyoshi M; Otani R; Tsuboi A; Tanaka H; Yamashita K; Hiyama Y; Urabe Y; Ishikawa A; Sentani K; Oka S
    Exp Mol Pathol; 2024 Jun; 137():104896. PubMed ID: 38703552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ErbB2 activation upregulates glutaminase 1 expression which promotes breast cancer cell proliferation.
    Qie S; Chu C; Li W; Wang C; Sang N
    J Cell Biochem; 2014 Mar; 115(3):498-509. PubMed ID: 24122876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Knockdown of PKM2 and GLS1 expression can significantly reverse oxaliplatin-resistance in colorectal cancer cells.
    Lu WQ; Hu YY; Lin XP; Fan W
    Oncotarget; 2017 Jul; 8(27):44171-44185. PubMed ID: 28498807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selenite inhibits glutamine metabolism and induces apoptosis by regulating GLS1 protein degradation via APC/C-CDH1 pathway in colorectal cancer cells.
    Zhao J; Zhou R; Hui K; Yang Y; Zhang Q; Ci Y; Shi L; Xu C; Huang F; Hu Y
    Oncotarget; 2017 Mar; 8(12):18832-18847. PubMed ID: 27902968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GLS1 depletion inhibited colorectal cancer proliferation and migration via redox/Nrf2/autophagy-dependent pathway.
    Liu HY; Zhang HS; Liu MY; Li HM; Wang XY; Wang M
    Arch Biochem Biophys; 2021 Sep; 708():108964. PubMed ID: 34119480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heat Shock Factor 1 Epigenetically Stimulates Glutaminase-1-Dependent mTOR Activation to Promote Colorectal Carcinogenesis.
    Li J; Song P; Jiang T; Dai D; Wang H; Sun J; Zhu L; Xu W; Feng L; Shin VY; Morrison H; Wang X; Jin H
    Mol Ther; 2018 Jul; 26(7):1828-1839. PubMed ID: 29730197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting glutaminase 1 attenuates stemness properties in hepatocellular carcinoma by increasing reactive oxygen species and suppressing Wnt/beta-catenin pathway.
    Li B; Cao Y; Meng G; Qian L; Xu T; Yan C; Luo O; Wang S; Wei J; Ding Y; Yu D
    EBioMedicine; 2019 Jan; 39():239-254. PubMed ID: 30555042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. iTRAQ-Based Quantitative Proteomics Approach Identifies Novel Diagnostic Biomarkers That Were Essential for Glutamine Metabolism and Redox Homeostasis for Gastric Cancer.
    Jiang Z; Zhang C; Gan L; Jia Y; Xiong Y; Chen Y; Wang Z; Wang L; Luo H; Li J; Zhu R; Ji X; Yu Q; Wang L
    Proteomics Clin Appl; 2019 Jul; 13(4):e1800038. PubMed ID: 30485682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of p53 by costunolide blocks glutaminolysis and inhibits proliferation in human colorectal cancer cells.
    Hu M; Liu L; Yao W
    Gene; 2018 Dec; 678():261-269. PubMed ID: 30103008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glutaminase 1 is essential for the differentiation, proliferation, and survival of human neural progenitor cells.
    Wang Y; Huang Y; Zhao L; Li Y; Zheng J
    Stem Cells Dev; 2014 Nov; 23(22):2782-90. PubMed ID: 24923593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of the glutamine metabolism-related proteins glutaminase 1 and glutamate dehydrogenase in canine mammary tumours.
    Ryu JE; Park HK; Choi HJ; Lee HB; Lee HJ; Lee H; Yu ES; Son WC
    Vet Comp Oncol; 2018 Jun; 16(2):239-245. PubMed ID: 29266697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glutaminase 1 plays a key role in the cell growth of fibroblast-like synoviocytes in rheumatoid arthritis.
    Takahashi S; Saegusa J; Sendo S; Okano T; Akashi K; Irino Y; Morinobu A
    Arthritis Res Ther; 2017 Apr; 19(1):76. PubMed ID: 28399896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated expression of glutaminase confers glucose utilization via glutaminolysis in prostate cancer.
    Pan T; Gao L; Wu G; Shen G; Xie S; Wen H; Yang J; Zhou Y; Tu Z; Qian W
    Biochem Biophys Res Commun; 2015 Jan; 456(1):452-8. PubMed ID: 25482439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of Glutaminase Expression in Prostate Adenocarcinoma and Correlation with Clinicopathologic Parameters.
    Myint ZW; Sun RC; Hensley PJ; James AC; Wang P; Strup SE; McDonald RJ; Yan D; St Clair WH; Allison DB
    Cancers (Basel); 2021 Apr; 13(9):. PubMed ID: 33947068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glutaminase (GLS1) gene expression in primary breast cancer.
    Vidula N; Yau C; Rugo HS
    Breast Cancer; 2023 Nov; 30(6):1079-1084. PubMed ID: 37679553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Expression of Glutaminases and their Association with Clinicopathological Parameters in the Head and Neck Cancers.
    Basheer HA; Elsalem L; Salem A; Tailor A; Hunter K; Afarinkia K
    Curr Cancer Drug Targets; 2022; 22(2):169-179. PubMed ID: 34951574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.